PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 78 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,672,000 | +7.4% | 400,000 | +77.8% | 2.19% | +6.9% |
| Q2 2023 | $6,214,500 | +20.1% | 225,000 | 0.0% | 2.05% | +34.1% |
| Q1 2023 | $5,175,000 | +221.8% | 225,000 | -1.2% | 1.53% | +259.2% |
| Q1 2020 | $1,608,000 | -17.1% | 227,827 | -17.2% | 0.43% | +15.4% |
| Q4 2019 | $1,939,000 | -35.4% | 275,000 | +10.0% | 0.37% | -51.8% |
| Q3 2019 | $3,003,000 | +24.0% | 250,000 | +25.0% | 0.76% | +52.4% |
| Q2 2019 | $2,422,000 | -72.5% | 200,000 | -71.4% | 0.50% | -78.2% |
| Q1 2019 | $8,799,000 | – | 700,000 | – | 2.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $43,400,000 | 3.81% |
| BVF INC/IL | 3,901,759 | $69,139,000 | 2.70% |
| COMMODORE CAPITAL LP | 498,079 | $8,826,000 | 2.33% |
| Altium Capital Management LP | 346,000 | $6,131,000 | 1.61% |
| Twin Lakes Capital Management, LLC | 139,287 | $2,468,000 | 1.45% |
| Opaleye Management Inc. | 330,222 | $5,852,000 | 1.09% |
| EcoR1 Capital, LLC | 1,443,800 | $25,584,000 | 0.89% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 776,689 | $13,763,000 | 0.76% |
| JABODON PT CO | 90,656 | $1,606,000 | 0.66% |
| Artal Group S.A. | 1,500,000 | $26,580,000 | 0.60% |